Skip to main content
Clinical Trials/NCT00405522
NCT00405522
Completed
Phase 3

Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children: Evaluation of Two Dose Combinations

The Hospital for Sick Children1 site in 1 country34 target enrollmentNovember 2006

Overview

Phase
Phase 3
Intervention
Propofol 2.0 mg/kg + Remifentanil 1.5 ug/kg
Conditions
Spinal Puncture
Sponsor
The Hospital for Sick Children
Enrollment
34
Locations
1
Primary Endpoint
Duration of Apnea
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The objective of this study is to compare intraoperative and recovery parameters in patients who receive two different dose combinations of propofol and remifentanil in patients undergoing a lumbar puncture.

Detailed Description

Lumbar punctures (LP) are performed in approximately one thousand oncology patients per year at the Hospital for Sick Children. In a previous study, we determined the optimal dose of remifentanil which provides effective anesthesia with little or no movement during LP in children. The present study will determine the optimal dose combination of propofol and remifentanil to keep patients comfortable and still during the procedure while decreasing the incidence of side effects and allows for shorter recovery times and earlier discharge from the recovery room.

Registry
clinicaltrials.gov
Start Date
November 2006
End Date
June 2007
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jason Hayes

Staff Anesthesiologist

The Hospital for Sick Children

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of a hemato-oncological disorder
  • Scheduled to undergo a lumbar puncture
  • Aged 3-12 years
  • Unpremedicated

Exclusion Criteria

  • children who are known or suspected to be difficult to ventilate by face mask
  • children who are deemed medically unfit to receive either of the two study medications
  • children who are obese (weight for height \> 95th percentile)
  • children who do not have an indwelling intravenous line

Arms & Interventions

Propofol 2.0 mg/kg + Remifentanil 1.5 ug/kg

Intervention: Propofol 2.0 mg/kg + Remifentanil 1.5 ug/kg

Propofol 4.0 mg/kg + Remifentanil 0.5 ug/kg

Intervention: Propofol 4.0 mg/kg + Remifentanil 0.5 ug/kg

Outcomes

Primary Outcomes

Duration of Apnea

Time Frame: This outcome was measured for the duration of the procedure (lumbar puncture).

Duration of no respiratory effort

Duration of Postoperative Recovery (Time to Spontaneous Eye Opening, Verbalization, Purposeful Movement).

Time Frame: This outcome was measured for the duration of the recovery phase.

Secondary Outcomes

  • Incidence of Adverse Events and Clinically Significant Changes in Routine Vital Signs as Measured by Electrocardiogram, Non-invasive Blood Pressure, and Pulse Oximeter.(This outcome was measured for the duration of the procedure (lumbar puncture).)

Study Sites (1)

Loading locations...

Similar Trials